BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND PICALM, CLTH, 8301, ENSG00000073921, CALM, Q13492 AND Treatment
13 results:

  • 1. treatment outcomes of childhood picalm::MLLT10 acute leukaemias.
    Mark C; Meshinchi S; Joyce B; Gibson B; Harrison C; Bergmann AK; Goemans BF; Pronk CJH; Lapillonne H; Leverger G; Antoniou E; Schneider M; Attarbaschi A; Dworzak M; Stary J; Tomizawa D; Ebert S; Lejman M; Kolb EA; Schmiegelow K; Hasle H; Abla O
    Br J Haematol; 2024 Feb; 204(2):576-584. PubMed ID: 37743097
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (calm): a phase 1, dose-escalation trial.
    Benjamin R; Jain N; Maus MV; Boissel N; Graham C; Jozwik A; Yallop D; Konopleva M; Frigault MJ; Teshima T; Kato K; Boucaud F; Balandraud S; Gianella-Borradori A; Binlich F; Marchiq I; Dupouy S; Almena-Carrasco M; Pannaux M; Fouliard S; Brissot E; Mohty M;
    Lancet Haematol; 2022 Nov; 9(11):e833-e843. PubMed ID: 36228643
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins.
    Steimlé T; Dourthe ME; Alcantara M; Touzart A; Simonin M; Mondesir J; Lhermitte L; Bond J; Graux C; Grardel N; Cayuela JM; Arnoux I; Gandemer V; Balsat M; Vey N; Macintyre E; Ifrah N; Dombret H; Petit A; Baruchel A; Ruminy P; Boissel N; Asnafi V
    Blood Cancer J; 2022 Jan; 12(1):14. PubMed ID: 35082269
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Melphalan 140 mg/m
    Auner HW; Iacobelli S; Sbianchi G; Knol-Bout C; Blaise D; Russell NH; Apperley JF; Pohlreich D; Browne PV; Kobbe G; Isaksson C; Lenhoff S; Scheid C; Touzeau C; Jantunen E; Anagnostopoulos A; Yakoub-Agha I; Tanase A; Schaap N; Wiktor-Jedrzejczak W; Krejci M; Schönland SO; Morris C; Garderet L; Kröger N
    Haematologica; 2018 Mar; 103(3):514-521. PubMed ID: 29217776
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Successful treatment of a Very Late Isolated Relapse in an Adolescent With a picalm-MLLT10 Positive T-lineage Acute Lymphoblastic Leukemia.
    Cannata E; Samperi P; Cimino C; Marino S; Sullo F; Mirabile E; Di Cataldo A; Russo G; Lo Nigro L
    J Pediatr Hematol Oncol; 2018 Apr; 40(3):e191-e194. PubMed ID: 29189509
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib treatment.
    Li W; Zhang J; Guo L; Chuai S; Shan L; Ying J
    J Thorac Oncol; 2017 Jan; 12(1):94-101. PubMed ID: 27614248
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements.
    Somers K; Chudakova DA; Middlemiss SM; Wen VW; Clifton M; Kwek A; Liu B; Mayoh C; Bongers A; Karsa M; Pan S; Cruikshank S; Scandlyn M; Hoang W; Imamura T; Kees UR; Gudkov AV; Chernova OB; Haber M; Norris MD; Henderson MJ
    Oncotarget; 2016 Jul; 7(29):46067-46087. PubMed ID: 27317766
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The prognosis of calm-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest.
    Ben Abdelali R; Asnafi V; Petit A; Micol JB; Callens C; Villarese P; Delabesse E; Reman O; Lepretre S; Cahn JY; Guillerm G; Berthon C; Gardin C; Corront B; Leguay T; Béné MC; Ifrah N; Leverger G; Dombret H; Macintyre E
    Haematologica; 2013 Nov; 98(11):1711-7. PubMed ID: 23831922
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Acute leukemia with picalm-MLLT10 fusion gene: diagnostic and treatment struggle.
    Savage NM; Kota V; Manaloor EJ; Kulharya AS; Pierini V; Mecucci C; Ustun C
    Cancer Genet Cytogenet; 2010 Oct; 202(2):129-32. PubMed ID: 20875875
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study.
    Asnafi V; Buzyn A; Thomas X; Huguet F; Vey N; Boiron JM; Reman O; Cayuela JM; Lheritier V; Vernant JP; Fiere D; Macintyre E; Dombret H
    Blood; 2005 Apr; 105(8):3072-8. PubMed ID: 15637138
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Propofol or propofol--alfentanil anesthesia for painful procedures in the pediatric oncology ward.
    Von Heijne M; Bredlöv B; Söderhäll S; Olsson GL
    Paediatr Anaesth; 2004 Aug; 14(8):670-5. PubMed ID: 15283827
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Hypermethylation of DAP-kinase gene CpG Island in malignant lymphoma with B-cell phenotype].
    Nakatsuka S; Takakuwa T; Aozasa K
    Rinsho Byori; 2001 Dec; 49(12):1242-7. PubMed ID: 11797395
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.